Michelle Robertson
2021 - Editas Medicine
Compensation breakdown
| Non-Equity Incentive Plan | $218,700 |
|---|---|
| Option Awards | $977,865 |
| Salary | $415,754 |
| Stock Awards | $627,408 |
| Other | $7,290 |
| Total | $2,247,017 |
Robertson received $977.9K in option awards, accounting for 44% of the total pay in 2021.
Robertson also received $218.7K in non-equity incentive plan, $415.8K in salary, $627.4K in stock awards and $7.3K in other compensation.
Rankings
In 2021, Michelle Robertson's compensation ranked 5,591st out of 12,415 executives tracked by ExecPay. In other words, Robertson earned more than 55.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,591 out of 12,415 | 55th |
Division Manufacturing | 2,368 out of 5,505 | 57th |
Major group Chemicals And Allied Products | 1,028 out of 2,375 | 57th |
Industry group Drugs | 917 out of 2,096 | 56th |
Industry Biological Products, Except Diagnostic Substances | 222 out of 449 | 51st |
Pay ratio
| Michelle Robertson's Pay | $2,247,017 |
|---|---|
| Median Employee's Pay | $181,354 |
| Pay Ratio | 12to 1 |
In 2021, the annual total compensation of Michelle Robertson was $2,247,017.
The annual total compensation of the median employee at Editas Medicine was $181,354.
The ratio of Michelle Robertson's pay to the pay of median employee was therefore 12 to one.
Robertson's colleagues
We found five more compensation records of executives who worked with Michelle Robertson at Editas Medicine in 2021.
2021
James Mullen
Editas Medicine
Chief Executive Officer
2021
Mark Shearman
Editas Medicine
Chief Scientific Officer
2021
Bruce Eaton
Editas Medicine
Executive Vice President and Chief Business Officer
2021
Lisa Michaels
Editas Medicine
Chief Medical Officer
2021
Cynthia Collins
Editas Medicine
Chief Executive Officer
News
April 26, 2022
April 20, 2021
April 24, 2020
April 26, 2019